Yakira Capital Management’s Urovant Sciences Ltd. UROV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-80,000
Closed -$1.29M 442
2020
Q4
$1.29M Buy
+80,000
New +$992K 0.31% 97

Yakira Capital Management's UROV Position: Q1 2021 in Review

Yakira Capital Management sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 80,000 shares — an estimated $1.29M sold.

Yakira Capital Management first reported a position in UROV in Q4 2020 and held it in 1 quarter. The position peaked at $1.29M in Q4 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

  • Yakira Capital Management reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
  • Yakira Capital Management sold 80,000 Urovant Sciences Ltd. shares in Q1 2021, an estimated $1.29M.
  • Yakira Capital Management first reported a position in Urovant Sciences Ltd. in Q4 2020 and held it in 1 quarter.
  • Yakira Capital Management's Urovant Sciences Ltd. position peaked at $1.29M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on Yakira Capital Management's 13F filing for Q1 2021, filed 14 May 2021.